Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on May 22, 2026

EaseOS by StoreEase Now Fully Integrated with Self Storage Manager (SSM)
Aircraft ACMI Leasing Market 2026-2030: Unveiling Growth Developments with the Latest Updates
Air Wave Pressure Circulation Therapy Apparatus Market CAGR to be at 10.6% from 2026 to 2030 | $1.62 Billion by 2030
Agile Internet Of Things (IoT) Market to Reach USD $103.82 Billion by 2030 at 17.6% CAGR
Affiliate Marketing Platform Global Market Report 2026| Business Growth, Development Factors, Trends till 2030
Adverse Media Screening Market to Reach $2.6 Billion by 2030 with 14.8% CAGR
Adventure Film Tour Travel Market Revenue To Cross $17.25 Billion By 2030 Supported By Rising Demand
Accessory Dwelling Unit (ADU) Lending Analytics Market Forecast To Hit $3.88Billion By 2030 Amid Strong Industry Growth
Global Adaptogenic Energy Bars Market To Expand A t11% CAGR During The Forecast Period
Biochips Market See Incredible Growth 2026-2033 with Key Players like Standard BioTools, bioMérieux
Calidi Biotherapeutics Provides Required NYSE American Disclosure
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
SCYNEXIS Announces One-for-Eight Reverse Stock Split
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars
Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
XTL Announces Receipt of Staff Delist Determination from Nasdaq
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Falkland Islands Science Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.